These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 10486318)

  • 1. Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors.
    Varley JM; McGown G; Thorncroft M; James LA; Margison GP; Forster G; Evans DG; Harris M; Kelsey AM; Birch JM
    Am J Hum Genet; 1999 Oct; 65(4):995-1006. PubMed ID: 10486318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of germline p53 mutations in childhood adrenocortical cancer.
    Wagner J; Portwine C; Rabin K; Leclerc JM; Narod SA; Malkin D
    J Natl Cancer Inst; 1994 Nov; 86(22):1707-10. PubMed ID: 7966399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers.
    Lipkin SM; Wang V; Stoler DL; Anderson GR; Kirsch I; Hadley D; Lynch HT; Collins FS
    Hum Mutat; 2001 May; 17(5):389-96. PubMed ID: 11317354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
    Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma.
    Raymond VM; Else T; Everett JN; Long JM; Gruber SB; Hammer GD
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E119-25. PubMed ID: 23175693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.
    Wasserman JD; Novokmet A; Eichler-Jonsson C; Ribeiro RC; Rodriguez-Galindo C; Zambetti GP; Malkin D
    J Clin Oncol; 2015 Feb; 33(6):602-9. PubMed ID: 25584008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
    Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV
    J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TP53 germline mutations in adult patients with adrenocortical carcinoma.
    Herrmann LJ; Heinze B; Fassnacht M; Willenberg HS; Quinkler M; Reisch N; Zink M; Allolio B; Hahner S
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E476-85. PubMed ID: 22170717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood predictive genetic testing for Li-Fraumeni syndrome.
    Evans DG; Lunt P; Clancy T; Eeles R
    Fam Cancer; 2010 Mar; 9(1):65-9. PubMed ID: 19404774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patient.
    Giacomazzi J; Selistre S; Duarte J; Ribeiro JP; Vieira PJ; de Souza Macedo G; Rossi C; Czepielewski M; Netto CB; Hainaut P; Ashton-Prolla P
    BMC Cancer; 2013 Apr; 13():187. PubMed ID: 23570263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation.
    Figueiredo BC; Sandrini R; Zambetti GP; Pereira RM; Cheng C; Liu W; Lacerda L; Pianovski MA; Michalkiewicz E; Jenkins J; Rodriguez-Galindo C; Mastellaro MJ; Vianna S; Watanabe F; Sandrini F; Arram SB; Boffetta P; Ribeiro RC
    J Med Genet; 2006 Jan; 43(1):91-6. PubMed ID: 16033918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history.
    Buttin BM; Powell MA; Mutch DG; Babb SA; Huettner PC; Edmonston TB; Herzog TJ; Rader JS; Gibb RK; Whelan AJ; Goodfellow PJ
    Am J Hum Genet; 2004 Jun; 74(6):1262-9. PubMed ID: 15098177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant.
    Berends MJ; Wu Y; Sijmons RH; Mensink RG; van der Sluis T; Hordijk-Hos JM; de Vries EG; Hollema H; Karrenbeld A; Buys CH; van der Zee AG; Hofstra RM; Kleibeuker JH
    Am J Hum Genet; 2002 Jan; 70(1):26-37. PubMed ID: 11709755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one.
    Goel A; Nguyen TP; Leung HC; Nagasaka T; Rhees J; Hotchkiss E; Arnold M; Banerji P; Koi M; Kwok CT; Packham D; Lipton L; Boland CR; Ward RL; Hitchins MP
    Int J Cancer; 2011 Feb; 128(4):869-78. PubMed ID: 20473912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenocortical tumors associated with the TP53 p.R337H germline mutation can be identified during child-care consultations.
    Mastellaro MJ; Ribeiro RC; Oliveira-Filho AG; Seidinger AL; Cardinalli IA; Miranda ECM; Aguiar SS; Brandalise SR; Yunes JA; Barros-Filho AA
    J Pediatr (Rio J); 2018; 94(4):432-439. PubMed ID: 28864397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.
    Lee DS; Yoon SY; Looi LM; Kang P; Kang IN; Sivanandan K; Ariffin H; Thong MK; Chin KF; Mohd Taib NA; Yip CH; Teo SH
    Breast Cancer Res; 2012 Apr; 14(2):R66. PubMed ID: 22507745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational germline analysis of hMSH2 and hMLH1 genes in early onset colorectal cancer patients.
    Montera M; Resta N; Simone C; Guanti G; Marchese C; Civitelli S; Mancini A; Pozzi S; De Salvo L; Bruzzone D; Donadini A; Romio L; Mareni C
    J Med Genet; 2000 Jul; 37(7):E7. PubMed ID: 10882759
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of Li-Fraumeni syndrome and Li-Fraumeni-like families for germline mutations in Bcl10.
    Stone JG; Eeles RA; Sodha N; Murday V; Sheriden E; Houlston RS
    Cancer Lett; 1999 Dec; 147(1-2):181-5. PubMed ID: 10660104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of germline TP53 mutations and history of Li-Fraumeni syndrome in families with childhood adrenocortical tumors, choroid plexus tumors, and rhabdomyosarcoma: a population-based survey.
    Magnusson S; Gisselsson D; Wiebe T; Kristoffersson U; Borg Å; Olsson H
    Pediatr Blood Cancer; 2012 Nov; 59(5):846-53. PubMed ID: 22653678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.